Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesViewRay Inc.

ViewRay Inc.

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
3000
Market Cap
0.02M

Momentum Score

…

ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control. Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
-
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

ViewRay makes MRIdian MRI-guided radiation therapy systems and provides related services and software for cancer treatment. Long-term growth could come from wider clinical adoption of MRI-guided radiotherapy, expansion of the installed base with recurring service and software revenue, and international penetration; the company may appeal to investors seeking exposure to a specialized, technology-driven segment of radiation oncology.
Key risks are intense competition from larger radiotherapy firms, long capital-intensive sales cycles with reimbursement sensitivity, and heightened financing and liquidity risk associated with OTC Pink trading and reduced public disclosure.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
105.86M
Revenue Per Share
0.58
Gross Profit TTM
8.52M
Debt / Equity
0.33
ROE
-108.91%
Net Debt
-112.07M
ROCE
-60.24%
Diluted EPS TTM
-6.10

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -107.33M -110.05M -107.91M -120.20M -76.40M
Net income -107.33M -110.05M -107.91M -120.20M -76.40M
Selling general administrative 82.92M 72.14M 76.91M 91.52M 50.11M
Selling and marketing expenses - - - - 15.06M
Gross profit 10.04M 0.34M -4.06M -5.48M 6.60M
Reconciled depreciation 4.92M 5.98M 6.42M 4.66M -
Ebit -105.31M -103.65M -105.98M -120.80M -68.76M
Ebitda -102.27M -105.81M -104.60M -115.87M -65.26M
Depreciation and amortization - - - - 3.50M
Operating income -105.31M -103.65M -105.98M -120.80M -75.09M
Other operating expenses - - - - 156.05M
Interest expense 5.06M 4.24M 3.31M 4.33M 7.70M
Tax provision 0.00M 0.00M 0.00M 0.00M -
Interest income 1.69M 0.01M 0.79M 1.72M -
Net interest income -3.37M -4.23M -2.52M -2.61M -
Total revenue 102.21M 70.12M 57.02M 87.78M 80.96M
Total operating expenses 207.52M 173.77M 162.99M 208.58M 81.69M
Cost of revenue 92.16M 69.78M 61.08M 93.26M 74.36M
Total other income expense net 1.35M -2.17M 0.58M 3.20M -1.30M
Net income from continuing ops -107.33M -110.05M -107.91M -120.20M -
Net income applicable to common shares -107.33M -110.05M -107.91M -120.20M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 271.40M 321.81M 261.55M 350.02M 294.97M
Other current assets 10.52M 6.64M 4.35M 5.57M 23.92M
Total liab 189.16M 152.01M 131.29M 133.84M 127.66M
Total stockholder equity 82.24M 169.79M 130.27M 216.17M 167.31M
Other current liab 42.40M 35.80M 26.95M 21.18M 5.58M
Common stock 1.81M 1.78M 1.48M 1.46M 0.95M
Capital stock 1.81M 1.78M 1.48M 1.46M -
Retained earnings -844.46M -737.13M -627.08M -519.18M -398.98M
Other liab 9.03M 13.67M 8.39M 10.30M -
Other assets 17.42M 8.31M 2.89M 2.98M -
Cash 135.96M 218.35M 156.72M 226.78M 167.43M
Total current liabilities 96.58M 76.24M 56.91M 59.07M 53.89M
Current deferred revenue - - - - 33.70M
Net debt - - - - -112.07M
Short long term debt - 3.22M - 1.56M -
Short long term debt total - - - - 55.36M
Other stockholder equity - - - - 565.33M
Property plant equipment 25.59M 29.90M 34.19M 35.12M -
Total current assets 228.35M 283.55M 224.43M 311.86M 277.68M
Net tangible assets 82.20M 169.75M 130.22M 216.12M -
Net receivables 41.38M 21.66M 11.77M 16.82M 36.87M
Long term debt 78.34M 54.03M 56.94M 53.99M -
Inventory 38.79M 34.40M 48.73M 61.49M 49.46M
Accounts payable 28.30M 9.20M 9.98M 13.74M 13.83M
Non currrent assets other 17.42M 8.31M 2.89M 2.98M 3.33M
Non current assets total 43.04M 38.26M 37.13M 38.16M 17.29M
Capital lease obligations 8.06M 10.63M 11.13M 12.74M -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -3.90M -1.56M -6.18M -7.82M -
Change to liabilities 23.27M 10.06M 1.10M -13.01M -
Total cashflows from investing activities -3.90M -1.56M -6.18M -7.82M -3.69M
Net borrowings 22.00M 22.00M 2.00M 2.00M -
Total cash from financing activities 18.29M 125.28M -0.35M 146.21M 236.71M
Change to operating activities -9.31M -0.13M -1.83M 11.71M -
Net income -107.33M -110.05M -107.91M -120.20M -76.40M
Change in cash -77.31M 61.63M -70.01M 58.82M 110.83M
Begin period cash flow 219.81M 158.18M 228.19M 169.37M 58.53M
End period cash flow 142.50M 219.81M 158.18M 228.19M 169.37M
Total cash from operating activities -91.71M -62.09M -63.47M -79.57M -122.19M
Issuance of capital stock 0.00M 137.88M 0.00M 149.56M -
Depreciation 5.02M 6.09M 6.48M 4.70M 3.43M
Change to inventory -4.26M 12.87M 12.61M -4.27M -32.21M
Change to account receivables -20.03M -9.89M 5.05M 20.05M -16.54M
Other cashflows from financing activities -1.87M -9.33M -1.35M -10.58M -6.17M
Change to netincome 19.51M 28.04M 20.29M 20.75M -
Capital expenditures 3.90M 1.56M 6.18M 7.76M 3.69M
Change in working capital -10.33M 12.91M 16.93M 14.48M -60.51M
Stock based compensation 21.61M 23.87M 22.80M 19.45M 14.17M
Other non cash items 1.02M 1.91M 0.94M 0.75M -2.96M
Free cash flow -95.61M -63.65M -69.66M -87.38M -125.88M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
VRAYQ
ViewRay Inc.		 -
-%		 0.00 - - 0.00 - 0.04
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95

Profile*

ViewRay Inc.

ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control. Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.

2 Thermo Fisher Way, Oakwood, OH, United States, 44146

855 915 4558

https://viewraysystems.com

295

Name Title Year Born
Mr. Paul Ziegler Jr., J.D. President, CEO & Director 1974
Dr. James F. Dempsey Ph.D. Founder & Chief Scientific Officer 1971
Mr. Andrew James Hill Senior Vice President of Operations & Development 1985
Matt Harrison Director of Investor Relations NA
Mr. Sanket Shah J.D. Senior VP & General Counsel 1983
Ms. Julianne Mast Vice President of Human Resources NA
Dr. Martin Fuss M.D., Ph.D. Chief Medical Officer NA
Mr. Adam Podbelski Senior Vice President of Commercial Operations NA
Mr. Steven Annen Senior Vice President of Global Marketing 1964

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…